UT Southwestern is a leader in robotic surgery for breast, liver and pancreatic cancer removal. Learn how these procedures reduce complications and improve outcomes.
The FDA has expanded its approval of belzutifan, a new kidney cancer drug, to treat metastatic renal cancer. Learn about UT Southwestern's role, from gene discovery to drug development.
After seeking a second opinion from a blood cancer specialist, William Marks discovered that chemotherapy was not his only treatment option for CLL. Learn how this saved his life.